Found: 40
Select item for more details and to access through your institution.
Regional healthy brain activity, glioma occurrence and symptomatology.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 1, p. 113, doi. 10.1007/s10549-019-05445-z
- By:
- Publication type:
- Article
Accelerated and quantitative three‐dimensional molecular MRI using a generative adversarial network.
- Published in:
- Magnetic Resonance in Medicine, 2023, v. 89, n. 5, p. 1901, doi. 10.1002/mrm.29574
- By:
- Publication type:
- Article
Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Labeling T Cells to Track Immune Response to Immunotherapy in Glioblastoma.
- Published in:
- Tomography: A Journal for Imaging Research, 2023, v. 9, n. 1, p. 274, doi. 10.3390/tomography9010022
- By:
- Publication type:
- Article
Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1835, doi. 10.1093/neuonc/noab152
- By:
- Publication type:
- Article
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 468, doi. 10.1093/neuonc/noaa240
- By:
- Publication type:
- Article
Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 189, doi. 10.1093/neuonc/noaa253
- By:
- Publication type:
- Article
Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 12, p. 1822, doi. 10.1093/neuonc/noaa105
- By:
- Publication type:
- Article
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 9, p. 1262, doi. 10.1093/neuonc/noaa141
- By:
- Publication type:
- Article
Dose diversification in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 701, doi. 10.1093/neuonc/noz063
- By:
- Publication type:
- Article
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 4, p. 546, doi. 10.1093/neuonc/nox161
- By:
- Publication type:
- Article
Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 2, p. 289, doi. 10.1093/neuonc/nox217
- By:
- Publication type:
- Article
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 567, doi. 10.1093/neuonc/now185
- By:
- Publication type:
- Article
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 10, p. 1386, doi. 10.1093/neuonc/nov085
- By:
- Publication type:
- Article
Is a picture really worth a 1000 words?
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 12, p. 1563, doi. 10.1093/neuonc/nou309
- By:
- Publication type:
- Article
INCREASED PERFUSION DUE TO VASCULAR NORMALIZATION IMPROVES OXYGENATION AND SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH CEDIRANIB WITH OR WITHOUT CHEMORADIATION.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii12, doi. 10.1093/neuonc/nou206.42
- By:
- Publication type:
- Article
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 8, p. 1079, doi. 10.1093/neuonc/not082
- By:
- Publication type:
- Article
Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 5, p. 466
- By:
- Publication type:
- Article
Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 5, p. 628, doi. 10.1007/s11864-024-01200-9
- By:
- Publication type:
- Article
The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
MRI and PET: Noninvasive Tools to Probe the Biology of Diffuse Intrinsic Pontine Glioma.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 8, p. 1262, doi. 10.2967/jnumed.117.192526
- By:
- Publication type:
- Article
Clinical management of seizures in patients with meningiomas: Efficacy of surgical resection for seizure control and patient-tailored postoperative anti-epileptic drug management.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, p. i58, doi. 10.1093/noajnl/vdac136
- By:
- Publication type:
- Article
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdac185
- By:
- Publication type:
- Article
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac128
- By:
- Publication type:
- Article
Magnetic resonance spectroscopic imaging for detecting metabolic changes in glioblastoma after anti-angiogenic therapy--a systematic literature review.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac103
- By:
- Publication type:
- Article
The Role of Antibody-Based Therapies in Neuro-Oncology.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 4, p. 74, doi. 10.3390/antib12040074
- By:
- Publication type:
- Article
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03905-6
- By:
- Publication type:
- Article
Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Glioblastoma care in the elderly.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 152, n. 3, p. 515, doi. 10.1007/s11060-021-03719-5
- By:
- Publication type:
- Article
Low Incidence of Pseudoprogression by Imaging in Newly Diagnosed Glioblastoma Patients Treated With Cediranib in Combination With Chemoradiation.
- Published in:
- Oncologist, 2014, v. 19, n. 1, p. 75, doi. 10.1634/theoncologist.2013-0101
- By:
- Publication type:
- Article
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. N.PAG, doi. 10.1038/s41598-018-34820-x
- By:
- Publication type:
- Article
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1219, doi. 10.1093/neuonc/noac086
- By:
- Publication type:
- Article
Volumetric measurements in low-grade glioma: Are we there yet?
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 5, p. 779, doi. 10.1093/neuonc/noac018
- By:
- Publication type:
- Article
Reply to Koekkoek et al. concerning SNO and EANO practice guideline update.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 501, doi. 10.1093/neuonc/noac015
- By:
- Publication type:
- Article
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198548
- By:
- Publication type:
- Article
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article